Search results
Emera (TSE:EMA) Price Target Raised to C$53.00 at Wells Fargo & Company
ETF DAILY NEWS· 4 days agoEmera (TSE:EMA – Free Report) had its price target hoisted by Wells Fargo & Company from C$49.00 to C$53.00 in a report published on Tuesday, BayStreet.CA reports. TD Securities ...
Emera Incorporated Forecasted to Earn Q3 2024 Earnings of $0.75 Per Share (TSE:EMA)
ETF DAILY NEWS· 3 days agoEmera Incorporated (TSE:EMA – Free Report) – Equities researchers at Raymond James cut their Q3 2024...
The Best Upcoming Crypto Investment: BlockDAG Lists on CoinMarketCap Amidst Stall in BNB and Solana...
Inside Bitcoins· 6 days agoCelebrating its new listing on CoinMarketCap, BlockDAG has even made a splash on the iconic screens...
Bitcoin Price Prediction as BTC Approaches $67,000 Level – New All Time High This Week?
Cryptonews· 20 hours agoAs Bitcoin edges close to $67,000, analysts speculate if a new all-time high is on the horizon,...
XRP Analyst Forecasts the Next Cycle Top for September 2024
Investing.com· 5 days agoEGRAG advises market readiness, noting that deviation from expected patterns by the target date...
Gold loses some ground but still bullish
The Forex Market· 6 days agoThe week began with gold losing ground and giving up the gains it made on Friday when it reached a two-week high of 2,378. Technically, the bounce back...
Altcoin Market Poised for Rally, Analysts Watch Three Key Indicators - EconoTimes
EconoTimes· 7 days agoThis stage, if history is any indication, could potentially lead to an 'explosive rally,' a term...
USD/JPY Forecast – US Dollar Continues to Pressure The Yen
FX Empire via Yahoo Finance· 5 days agoThe US Dollar continues to rise against the yen, as the market is likely to continue its momentum as...
Earnings call: Panbela Therapeutics reports on ASPIRE trial progress By Investing.com
Investing.com· 3 days agoPanbela Therapeutics, the biopharmaceutical company focused on developing treatments for cancer, has...
Earnings call: Ocugen reports progress in gene therapy trials and Q1 financials By Investing.com
Investing.com· 4 days agoDrug (IND) application by the FDA for the OCU400 Phase 3 limelight clinical trial, with patient...
